Fourteen novel 1,3-thiazolidin-4-ones were efficient obtained.
Antitumor C6 assay highlights two compounds with activity at 5 μM.
Three of top four on anti-tumor test were not cytotoxic to normal cell at 250 μM.
Thiazolidinones as potential anti-GBM effect with safe therapeutic profile.